Kleo Evripidou

Ms. Kleo Evripidou

Aristotle University of Thessaloniki, Thessaloníki, Kentrikí Makedonía, Greece
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2021 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
VPVictoria Potoupni
Victoria Potoupni
MGMaria Georgiadou
Maria Georgiadou
ECEftychia Chatzigriva
Eftychia Chatzigriva
GPGeorgia Polychronidou
Georgia Polychronidou
EMErietta Markou
Erietta Markou
SPStergios A Polyzos
Stergios A Polyzos

Dimitra Rafailia BakaloudiDimitra Rafailia Bakaloudi
Dimitra Rafailia Bakaloudi
KEKleo Evripidou
Kleo Evripidou
RJRanil Jayawardena
Ranil Jayawardena
JBJoão Breda
João Breda
TDTheodoros Dardavessis
Theodoros Dardavessis
MCMichael Chourdakis
Michael Chourdakis
The Coronavirus disease 2019 (COVID-19) has been characterized by the World Health Organization as a pandemic in March 2020 and the lockdown measures that were implemented in an effort to limit the transmission of the virus affected the daily life of many people in all over the world. The aim of this systematic review was to investigate the changes during/after the lockdowns in caffeine consumption by coffee and energy drinks. A systematic literature search was conducted in three databases (PubMed, Embase, Web of Science) up to 31 December 2021 and out of 19,511 studies found and 12,885 screened, 16 studies were included according to eligibility criteria. Results regarding coffee consumption showed that a significant part of individuals decreased their consumption and in five studies an increase was reported, including women and seniors >60 years old. Energy drinks were also consumed less during the lockdown compared to the pre-lockdown time. Attention should be given for menopausal women where an increase in coffee consumption was found which could impair bone density, but further research is needed in order to make safe conclusions.

30 August 2023 in Children
Verified
Journal Article
Open access
PDF file
IKIoustini Kalaitzopoulou
Ioustini Kalaitzopoulou
XTXenophon Theodoridis
Xenophon Theodoridis
Evangelia KotzakioulafiEvangelia Kotzakioulafi
Evangelia Kotzakioulafi
KEKleo Evripidou
Kleo Evripidou
MCMichael Chourdakis
Michael Chourdakis
(1) Background: This systematic review and meta-analysis aims to evaluate the impact of a low glycemic index (LGI) and low glycemic load (LGL) diet on children with overweight and obesity, analyzing any changes in anthropometric, cardiometabolic, and glucometabolic parameters. (2) Methods: Three electronic databases (PubMed, Scopus, CENTRAL), as well as clinical trial registries and reference lists of the included studies, were searched for eligible randomized control trials (RCTs). Two independent reviewers performed the screening of the studies, data extraction, and risk of bias assessment. Mean difference (MD) and 95% confidence intervals (CI) using a random effects model were calculated for each outcome. (3) Results: Eleven RCTs (n = 634) examining the effect of LGI diet versus control were identified. The synthesized data provided from the RCTs indicate no difference between intervention and control groups regarding primary outcomes (body weight (MD: −0.14; 95% CI −1.93 to 1.64, 5 trials), body mass index (BMI) (MD: −0.31; 95% CI −0.85 to 0.23, 6 trials), BMI z-score (MD: −0.03; 95% CI −0.09 to 0.02, 5 trials), and waist circumference (MD: −0.52; 95% CI −2.35 to 1.31, 5 trials)) and other measures of cardiometabolic and glucometabolic parameters. The majority of trials were classified as “some concerns”. (4) Conclusions: LGI and LGL diets do not seem to be associated with changes in adiposity, cardiometabolic or glucometabolic markers in children with overweight or obesity. Further research comparing the LGI diet to a high glycemic index diet, with proper methodological standards, is required to clarify the benefits of a LGI diet in this population.

5 February 2025 in Pediatric Nephrology
Verified
Journal Article
Open access
PDF file
KEKleo Evripidou
Kleo Evripidou
ACAthanasia Chainoglou
Athanasia Chainoglou
VKVasilios Kotsis
Vasilios Kotsis
Stella V. StabouliStella V. Stabouli
Stella V. Stabouli
Childhood obesity is a well-known risk factor for primary hypertension (HTN), especially during puberty. Validated automated oscillometric devices based on universal protocols using proper cuffs according to arm sizes must be selected for blood pressure (BP) measurement in clinical practice. Recent recommendations have addressed the importance of accurate BP measurement in patients with obesity. The American Heart Association (AHA) suggests using a cone-shaped cuff, while the European Society of Hypertension (ESH) emphasizes the significance of cuff characteristics based on arm size. The applicability of cone-shaped cuffs over cylindrical cuffs has been studied in adults with obesity. Most studies focused on the upper arm’s shape and provided evidence that the use of cylindrical cuffs may overestimate BP in individuals with obesity, while the conical cuff was proposed as a proper alternative. However, current validation studies for BP measurement devices have not included the arm’s size as a recruiting criterion, which may compromise the accuracy of devices in individuals with obesity. This review discusses the role of arm characteristics in cuff selection and the potential role of conical cuffs as an alternative to commonly used cylindrical ones in BP measurement in pediatric patients with obesity. Graphical abstract

27 November 2025 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
KEKleo Evripidou
Kleo Evripidou
ACAthanasia Chainoglou
Athanasia Chainoglou
CAChristina Antza
Christina Antza
CSCarla Simao
Carla Simao
IGIoannis Goulas
Ioannis Goulas
Stella V. StabouliStella V. Stabouli
Stella V. Stabouli